National Healthcare Corp. (NHC) is a publicly traded Healthcare sector company. As of May 21, 2026, NHC trades at $199.51 with a market cap of $3.07B and a P/E ratio of 24.87. NHC moved +1.28% today. Year to date, NHC is +52.38%; over the trailing twelve months it is +88.84%. Its 52-week range spans $89.14 to $205.06. Rallies surfaces NHC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who is trading NHC stock inside the company?
Recent NHC insider activity includes Shelly Timothy J. sold 2.45K, HASSAN EMIL E sold 7.50K, and Flatt Stephen Fowler sold 1.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
NHC Key Metrics
Key financial metrics for NHC
Metric
Value
Price
$199.51
Market Cap
$3.07B
P/E Ratio
24.87
EPS
$7.98
Dividend Yield
0.67%
52-Week High
$205.06
52-Week Low
$89.14
Volume
5
Avg Volume
0
Revenue (TTM)
$1.53B
Net Income
$126.42M
Gross Margin
0.00%
Recent NHC Insider Trades
Shelly Timothy J. sold 2.45K (~$342.14K) on Dec 17, 2025.
HASSAN EMIL E sold 7.50K (~$1.04M) on Nov 25, 2025.
Flatt Stephen Fowler sold 1.00K (~$130.33K) on Nov 21, 2025.
NHC analyst coverage data. Average price target: $0.00.
Common questions about NHC
Who is trading NHC stock inside the company?
Recent NHC insider activity includes Shelly Timothy J. sold 2.45K, HASSAN EMIL E sold 7.50K, and Flatt Stephen Fowler sold 1.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for NHC?
Yes. Rallies tracks NHC insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is NHC research on Rallies investment advice?
No. Rallies provides research, data, and educational context for NHC. It does not provide personalized investment advice.
